| 15d-PGJ2-G | 15-Desoxy-Δ12,14-prostaglandin-J2-glycerol ester |
| 2-AG | 2-Arachinoylglycerol |
| 5-HT1a | Serotonin 1A receptor |
| ABHD | α/β Hydrolase domain |
| AEA | N-Arachidonoyl-ethanolamine |
| AJA | Ajulemic acid |
| BBB | Blood brain barrier |
| BCP | β-Caryophyllene |
| CB1R | Cannabinoid receptor type 1 |
| CB2R | Cannabinoid receptor type 2 |
| CBC | Cannabichromene |
| CBCQ | Cannabichromenquinone |
| CBD | Cannabidiol |
| CBDA | Cannabidiolic acid |
| CBDQ | Cannabidiol hydroxyquinone |
| CBG | Cannabigerol |
| CBGA | Cannabigerolic acid |
| CBGQ | Cannabigeroquinone |
| CBM | Cannabimovone |
| CBN | Cannabinol |
| CBNQ | Cannabinolquinone |
| CBR | Cannabinoid receptor |
| Cryo-EM | Cryo electron microscopy |
| DGL | Diacylglycerol lipase |
| DIO | Diet-induced obese |
| ECS | Endocannabinoid System |
| EMI | Mangifera indica |
| EMT | Endocannabinoid membrane transporter |
| FA2H | Fatty acid 2-hydroxylase |
| FAAH | Fatty acid amide hydrolase |
| FABP | Fatty acid binding protein |
| GlyR | Glycine receptor |
| GPCR | G-Protein coupled receptor |
| LBD | Ligand binding domain |
| MAGL | Monoacylglycerol lipase |
| MD | Molecular dynamic |
| MHK | 4′-O-Methylhonokiol |
| NAAA | N-Acylethanolamine acid amidase |
| NAFLD | Non-alcoholic fatty liver disease |
| NAPE-PLD | N-Acyl phosphatidylethanolamine-specific phospholipase D |
| OEA | Oleoylethanolamide |
| OlGly | Oleoyl glycine |
| OLHHA | Oleic acid–dihydroxyamphetamine |
| PEA | Palmitoylethanolamide |
| PPAR | Peroxisome proliferator-activated receptors |
| PPRE | Peroxisome proliferator response element |
| THC | Δ9-Tetrahydrocannabinol |
| THCA | Δ9-Tetrahydrocannabinolic acid |
| TRP | Transient receptor potential |
| TRPM | Transient receptor potential melastatin |
| TZD | Thiazolidinedione |
| T2DM | Type 2 diabetes mellitus |